Soft tissue augmentation material

An injectable implant composition comprising biocompatible ceramic particles present in a pharmaceutically acceptable fluid carrier, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

A method for preparing injectable implant compositions, said method comprising combining ceramic particles and a pharmaceutically acceptable fluid carrier, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

A kit comprising:

• a syringe loaded with a volume of biocompatible ceramic particles which have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m present in a fluid carrier.

An injectable implant composition comprising ceramic particles composed of calcium phosphate mineral and having minimized surface porosity present in a pharmaceutically acceptable fluid carrier, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

An injectable implant composition comprising biocompatible ceramic particles present in a pharmaceutically acceptable fluid carrier in an amount from 15 to 50% by volume of the total composition, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

An injectable implant composition comprising biocompatible ceramic particles present in a biocompatible organic polymer which will dissipate from a tissue injection site leaving the ceramic particles, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

An injectable implant composition comprising biocompatible ceramic particles and a biocompatible fluid lubricant, present in a pharmaceutically acceptable fluid carrier, wherein the ceramic particles have been size selected to have a size distribution in the range from 15 .mu.m to 150 .mu.m.

A method for preparing injectable implant compositions, said method comprising combining ceramic particles and a pharmaceutically acceptable fluid carrier wherein the ceramic particles have been treated to minimize surface porosity prior to combining and have been size selected to have a size from 15 .mu.m to 150 .mu.m.

A method for preparing injectable implant compositions, said method comprising combining ceramic particles in a pharmaceutically acceptable fluid carrier in an amount from 15 to 50% by volume of the total composition, wherein the ceramic particles have been size selected to have a size from 15 .mu.m to 150 .mu.m.

A method for preparing injectable implant compositions, said method comprising combining ceramic particles and a biocompatible fluid lubricant in a pharmaceutically acceptable fluid carrier, wherein the ceramic particles have been size selected to have a size from 15 .mu.m to 150 .mu.m.